KR101124783B1 - Medium composition for Phellinus linteus culture - Google Patents

Medium composition for Phellinus linteus culture Download PDF

Info

Publication number
KR101124783B1
KR101124783B1 KR1020080079845A KR20080079845A KR101124783B1 KR 101124783 B1 KR101124783 B1 KR 101124783B1 KR 1020080079845 A KR1020080079845 A KR 1020080079845A KR 20080079845 A KR20080079845 A KR 20080079845A KR 101124783 B1 KR101124783 B1 KR 101124783B1
Authority
KR
South Korea
Prior art keywords
extract
weight
culture
glucan
medium composition
Prior art date
Application number
KR1020080079845A
Other languages
Korean (ko)
Other versions
KR20100021110A (en
Inventor
한일영
한태영
Original Assignee
한일영
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 한일영 filed Critical 한일영
Priority to KR1020080079845A priority Critical patent/KR101124783B1/en
Publication of KR20100021110A publication Critical patent/KR20100021110A/en
Application granted granted Critical
Publication of KR101124783B1 publication Critical patent/KR101124783B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01GHORTICULTURE; CULTIVATION OF VEGETABLES, FLOWERS, RICE, FRUIT, VINES, HOPS OR SEAWEED; FORESTRY; WATERING
    • A01G18/00Cultivation of mushrooms
    • A01G18/20Culture media, e.g. compost
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01GHORTICULTURE; CULTIVATION OF VEGETABLES, FLOWERS, RICE, FRUIT, VINES, HOPS OR SEAWEED; FORESTRY; WATERING
    • A01G18/00Cultivation of mushrooms
    • A01G18/40Cultivation of spawn
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Botany (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

본 발명은 베타글루칸의 함량을 높인 상황버섯 균사체 배양용 배지 조성물에 관한 것으로, 보다 상세하게는 상황버섯 균사체를 한약재 추출물에 배양하여 베타글루칸 함량을 증가시키는 것을 특징으로 한다. The present invention relates to a medium mushroom mycelium culture medium composition with a higher content of beta glucan, and more particularly, to increase the content of beta glucan by culturing the mycelium mushroom mycelium in an herbal medicine extract.

상황버섯, 배지조성, 베타글루칸 Situation Mushroom, Medium Composition, Beta Glucan

Description

상황버섯 균사체 배양용 배지 조성물{Medium composition for Phellinus linteus culture}Medium composition for Phellinus linteus culture

본 발명은 상황버섯 균사체 배양용 배지 조성물에 관한 것이다.The present invention relates to a medium composition for cultured mushroom mycelium.

버섯류는 생물의 분류체계상 담자균류에 속하는 미생물로서, 오래전부터 식용으로 사용되어 왔으며, 또한 각종 질병에 대한 민간 전통약재로 전래 되어 왔다. 현재 지구상에는 약 15,000여종의 버섯이 자생하고 있는데, 독성이 있는 것을 제외하면 대부분 식용으로 사용이 가능하다. 이러한 버섯류는 다당류인 글루칸 및 그 유도체를 다량 함유하고 있는 것으로 보고되어 있는데, 글루칸과 같은 다당류는 항암작용이 있는 것으로 알려져 있다. Mushrooms are microorganisms belonging to basidiomycetes in the classification system of organisms, and have been used for food for a long time and have been introduced as folk traditional medicine for various diseases. There are about 15,000 mushrooms growing naturally on earth, but most of them can be used for food, except those that are toxic. These mushrooms are reported to contain a large amount of polysaccharide glucan and its derivatives, polysaccharides such as glucan is known to have an anticancer action.

베타글루칸은 다당류의 일종으로서 인간의 정상적인 세포조직의 면역기능을 활성화시켜 암세포의 증식과 재발을 억제하고 면역세포의 기능을 활발하게 하는 인터루킨(interleukin), 인터페론(interferon)의 생성을 촉진시킨다. 활성 베타글루칸은 암세포가 있는 체내로 들어가 사이토카인(Cytokine)을 생산시킴으로써 면역 세포인 T세포와 B세포의 활동을 지원하여 세포조직의 면역기능을 활성화 시켜준다.Beta-glucan is a type of polysaccharide that activates the immune function of human normal cellular tissues, inhibits the proliferation and recurrence of cancer cells, and promotes the production of interleukin and interferon that activate immune cells. Active beta glucan enters the body where cancer cells are located and produces cytokines (Cytokine) to support the activity of immune cells, T cells and B cells, thereby activating the immune function of cellular tissues.

또한 버섯은 대부분 식용으로 사용되고 있어서, 부작용이 적고, 독성 면에서 도 안전함과 아울러 인체 면역 기능을 강화시키고 항암효과가 탁월한 것으로 알려져 있다. 특히 상황버섯은 다른 버섯과 비교할 때 면역증강제, 항암제로서의 효과가 탁월한 것으로 알려져 있지만 다년생으로 자연계에서 번식이 잘 되지 않는다. 또한, 자원 고갈과 생태계 파괴라는 문제가 있어서 자실체 입수가 매우 어렵다. 상황버섯은 세계적으로 널리 분포되어 있으나 자연에서 자실체 형성이 잘 되지 않는다.In addition, mushrooms are mostly used for food, so it is known to have fewer side effects, safer in terms of toxicity, strengthen human immune function, and have excellent anti-cancer effects. In particular, the situation mushroom is known to be excellent as an immune enhancer and anticancer agent compared to other mushrooms, but it is a perennial and does not reproduce well in nature. In addition, there is a problem of resource depletion and ecosystem destruction, so it is very difficult to obtain fruiting bodies. Situation mushrooms are widely distributed throughout the world, but the fruiting bodies are not well formed in nature.

종래의 상황버섯 인공재배 방법으로는 톱밥과 같은 여러 가지 목재 부산물, 곡물을 혼합한 것, 한약재 부산물을 이용하여 자실체를 재배하는 방법이 있다. 그러나, 상황버섯 자실체를 인공재배하는 종래의 방법은 3~6개월이라는 장기간의 배양기간이 소요되어 대량생산이 어렵고 수요를 충족시키지 못하고 있다. 반면 상황버섯 균사체의 배양은 자실체 형성에 소요되는 시간을 단축시킬 수 있을 뿐만 아니라 단시간에 다량의 다당류를 얻을 수 있다는 장점이 있다. 그러나 종래의 상황버섯 균사체 배양방법은 까다로운 배양조건으로 인해 대량생산이 어려운 실정이다. 이와 같이, 상황버섯은 항암제, 면역증강제로서 효과가 있음에도 불구하고 그 공급이 제한적이고 대량생산 및 속성생산이 용이하지 아니하여 널리 활용되지 못하고 있다.Conventional situation mushroom artificial cultivation method is a variety of wood by-products, such as sawdust, a mixture of grains, there is a method of cultivating fruiting body by using herbal medicine by-products. However, the conventional method for artificially cultivating the situation mushroom fruiting body takes a long period of 3-6 months of cultivation is difficult to mass production and does not meet the demand. On the other hand, the cultivation of the situation mushroom mycelium has the advantage that not only shortens the time required for fruiting body formation, but also obtains a large amount of polysaccharides in a short time. However, the conventional situation mushroom mycelium culture method is difficult to mass production due to the difficult culture conditions. As such, although the situation mushroom is effective as an anticancer agent and an immune enhancer, its supply is limited and mass production and rapid production are not easy, and thus are not widely used.

상황버섯 인공배양에 관련된 선행기술로서 대한민국 특허 등록번호 제51056호(등록일 1992.04.24)는 뽕나무, 뽕나무 톱밥 미강을 혼합한 것을 배지로 하여 상황버섯 균사체를 배양하는 방법을 개시하고 있으나 이 기술의 배양배지의 주원료가 되는 뽕나무 또는 그 고목을 쉽게 구할 수 없으므로 배양배지의 대량제조가 어려우며 본 배양기간이 50~60일로써 장기간이 소요되는 문제가 있다.As a prior art related to artificial mushroom culture, Korean Patent Registration No. 51056 (Registration date 1992.04.24) discloses a method of cultivating a mushroom mushroom mycelium by using a mixture of mulberry and mulberry sawdust rice bran as a medium. Mulberry or the old tree, which is the main raw material of the medium, is difficult to obtain, so it is difficult to manufacture a large amount of culture medium, and the culture period is 50 to 60 days, which takes a long time.

또한 대한민국 특허 등록번호 제204984호(등록일 1999.03.31)에서는 펠리누스 린테우스 균사체의 배양배지 성분으로서 곡류를 이용하는 방법을 개시하고 있으나, 이 방법 역시 60일의 본 배양시간이 필요하여 경제적이지 못한 문제점이 있다.In addition, Korean Patent Registration No. 204984 (Registration Date 1999.03.31) discloses a method of using cereals as a culture medium component of Felinus linteus mycelium, but this method also requires 60 days of incubation time, which is not economical. have.

이에, 본 발명자들은 한약재 추출물을 이용하여 상황버섯 균사체를 배양하였을 경우, 배양생성물 내에서 베타글루칸의 함량이 증가하는 것을 확인하고 본 발명을 완성하였다.Thus, the present inventors have confirmed that the content of beta glucan in the culture product when the cultured mycelium mushroom mycelium using the herbal extracts to complete the present invention.

따라서 본 발명의 주된 목적은 상황버섯 균사체 추출물 내의 베타글루칸 함량을 높이는 상황버섯 균사체 배양용 배지 조성물을 제공하는데 있다.Therefore, the main object of the present invention is to provide a medium composition for culturing mushroom mycelium to increase the content of beta glucan in the extract of mushroom mushroom mycelium.

상기와 같은 목적을 달성하기 위하여 본 발명은 인삼, 황기, 애엽(약쑥), 당귀, 상백피(뽕나무껍질) 및 오가피 추출물로 구성된 한약재 추출물 5-20 중량%, 감자전분 0.2-1 중량%, 덱스트로우즈 1-5 중량% 및 증류수 75-90 중량%를 포함하는 것을 특징으로 하는 상황버섯 균사체 배양용 배지 조성물을 제공한다. 또한 인삼, 황기, 애엽(약쑥), 당귀, 상백피(뽕나무껍질) 및 오가피 추출물로 구성된 한약재 추출물 5-20 중량%, 맥아추출물 1-5 중량% 및 증류수 75-90 중량%를 포함하는 것을 특징으로 하는 상황버섯 균사체 배양용 배지 조성물을 제공한다. In order to achieve the above object, the present invention is composed of ginseng, Astragalus, larvae (mugwort), Angelica, Sangbaekpi (Mulberry bark), and medicinal herb extract 5-20 wt%, potato starch 0.2-1 wt%, dextrose It provides a medium mushroom culture mycelium culture medium composition comprising 1-5% by weight of woods and 75-90% by weight of distilled water. In addition, it is characterized in that it comprises 5-20% by weight of the herbal medicine extract consisting of ginseng, Astragalus, larvae (mugwort), Angelica, sangbaekpi (Mulberry bark) and Ogapi extract, 1-5% by weight of malt extract and 75-90% by weight of distilled water. It provides a medium composition for culturing mushroom mycelium.

본 발명은 베타글루탄 함량이 높은 상황버섯 균사체를 배양하기 위한 배지 조성물에 관한 것이다. The present invention relates to a medium composition for culturing situation mushroom mycelium having a high content of beta glutan.

본 발명의 제 1의 양태는 인삼, 황기, 애엽(약쑥), 당귀, 상백피(뽕나무껍질) 및 오가피 추출물로 구성된 한약재 추출물 5-20 중량%, 감자전분 0.2-1 중량%, 덱스트로우즈 1-5 중량% 및 증류수 75-90 중량%를 포함하는 것을 특징으로 하는 상황버섯 균사체 배양용 배지 조성물을 제공한다.The first aspect of the present invention is 5-20% by weight of Chinese herbal medicine extract consisting of ginseng, Astragalus, larvae (mugwort), Angelica, Morus bark (Mulberry bark) and Ogapi extract, 0.2-1% by weight potato starch, dextrose 1- It provides a culture medium composition for the situation mushroom mycelium culture comprising 5% by weight and 75-90% by weight of distilled water.

본 발명의 제 2의 양태는 인삼, 황기, 애엽(약쑥), 당귀, 상백피(뽕나무껍질) 및 오가피 추출물로 구성된 한약재 추출물 5-20 중량%, 맥아추출물 1-5 중량% 및 증류수 75-90 중량%를 포함하는 것을 특징으로 하는 상황버섯 균사체 배양용 배지 조성물을 제공한다. The second embodiment of the present invention is 5-20% by weight of the herbal medicine extract consisting of ginseng, Astragalus, Aerobaia, Mugwort, Morus bark (Mulberry bark) and Ogapi extract, 1-5% by weight of malt extract and 75-90% by distilled water. It provides a culture medium composition for the situation mushroom mycelium culture comprising a%.

보다 상세하게는 상기 한약재 추출물은 인삼 200g, 황기 200g, 애엽(약쑥) 200g, 당귀 200g, 상백피(뽕나무껍질) 100g 및 오가피 100g을 2L의 정제수에 첨가한 후 110℃에서 2시간 중탕하여 추출된 것을 특징으로 한다.More specifically, the herbal medicine extract ginseng 200g, Astragalus 200g, Aegye (mugwort) 200g, Angelica 200g, Morus bark (mulberry bark) 100g and 100g of ogapi in 2L purified water and then extracted by boiling water at 110 ℃ for 2 hours It features.

이하, 실시예에 의하여 본 발명을 더욱 상세히 설명하고자 한다.Hereinafter, the present invention will be described in more detail with reference to Examples.

단, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 실However, the following examples are merely to illustrate the present invention, the contents of the present invention

시예에 한정되는 것은 아니다.It is not limited to an example.

< < 실시예Example 1 > 한약재 추출물 포함  1> Herbal Medicine Extract 포테이토Potato 덱스트로우즈Dextrose 배지에서 상황버섯 균사체 배양 Situation Mushroom Mycelium Culture in Medium

한약재 추출물은 인삼 200g, 황기 200g, 애엽(약쑥) 200g, 당귀 200g, 상백피(뽕나무껍질) 100g 및 오가피 100g을 2L의 정제수에 첨가한 후 110℃에서 2시간 동안 중탕하여 제조하였다. The herbal extracts were prepared by adding 200 g of ginseng, 200 g of Astragalus, 200 g of Aegye (mugwort), 200 g of Angelica vulgaris, 100 g of Morus bark (Mulberry bark), and 100 g of Ogapi in 2 L of purified water and then hot water at 110 ° C for 2 hours.

증류수 1L에 한약재 추출물 10%, 감자전분 0.4% 및 덱스트로우스 2%를 첨가하여 액체배지를 제조한 후 오토클레이브에서 15분간 멸균하였다. 상기에서 얻은 멸균된 배지에 상황버섯 균사의 종균을 무균적으로 접종하고 30℃에서 20일간 배양하여 배양액을 얻었다. 10% herbal extract, 0.4% potato starch and 2% dextrose were added to 1 L of distilled water to prepare a liquid medium and sterilized for 15 minutes in an autoclave. Aseptic inoculation of the spawn mushroom mycelium in the sterile medium obtained above and incubated for 20 days at 30 ℃ to obtain a culture solution.

< < 실시예Example 2 > 한약재 추출물 포함  2> Herbal Medicine Extract 말트Malt 익스트렉트Extract 배지에서 상황버섯 균사체 배양 Situation Mushroom Mycelium Culture in Medium

한약재 추출물은 인삼 200g, 황기 200g, 애엽(약쑥) 200g, 당귀 200g, 상백피(뽕나무껍질) 100g 및 오가피 100g을 2L의 정제수에 첨가한 후 110℃에서 2시간 동안 중탕하여 제조하였다. The herbal extracts were prepared by adding 200 g of ginseng, 200 g of Astragalus, 200 g of Aegye (mugwort), 200 g of Angelica vulgaris, 100 g of Morus bark (Mulberry bark), and 100 g of Ogapi in 2 L of purified water and then hot water at 110 ° C for 2 hours.

증류수 1L에 한약재 추출물 10%와 맥아추출물 2%를 첨가하여 액체배지를 제조한 후 오토클레이브에서 15분간 멸균하였다. 상기에서 얻은 멸균된 배지에 상황버섯 균사의 종균을 무균적으로 접종하고 30℃에서 20일간 배양하여 배양액을 얻었다. 10% herbal extract and 1% malt extract were added to 1 L of distilled water to prepare a liquid medium and sterilized for 15 minutes in an autoclave. Aseptic inoculation of the spawn mushroom mycelium in the sterile medium obtained above and incubated for 20 days at 30 ℃ to obtain a culture solution.

< < 비교예Comparative example 1 >  1> 포테이토Potato 덱스트로우즈Dextrose 배지를 이용한 상황버섯 균사체 배양 Situation Mushroom Mycelium Culture Using Medium

증류수 1L에 감자전분 0.4%g 및 덱스트로우스 2%를 첨가하여 액체배지를 제 조한 후 오토클레이브에서 15분간 멸균하였다. 상기에서 얻은 멸균된 배지에 상황버섯 균사의 종균을 무균적으로 접종하고 30℃에서 20일간 배양하여 배양액을 얻었다.0.4% g of potato starch and 2% dextrose were added to 1 L of distilled water to prepare a liquid medium and sterilized for 15 minutes in an autoclave. Aseptic inoculation of the spawn mushroom mycelium in the sterile medium obtained above and incubated for 20 days at 30 ℃ to obtain a culture solution.

< < 비교예Comparative example 2 >  2> 말트Malt 익스트렉트Extract 배지를 이용한 상황버섯 균사체 배양 Situation Mushroom Mycelium Culture Using Medium

증류수 1L에 맥아추출물 2%를 첨가하여 액체배지를 제조한 후 오토클레이브에서 15분간 멸균하였다. 상기에서 얻은 멸균된 배지에서 상황버섯 균사의 종균을 무균적으로 접종하고 30℃에서 20일간 배양하여 배양액을 얻었다.Malt extract 2% was added to 1 L of distilled water to prepare a liquid medium, and then sterilized for 15 minutes in an autoclave. Inoculated aseptic seed of the mushroom mushroom mycelium in the sterile medium obtained above and incubated for 20 days at 30 ℃ to obtain a culture solution.

< < 실시예Example 3 > 상황버섯 균사체 추출물 분말 제조 및 추출물 분말 내  3> Situation Mushroom Mycelia Extract Powder Preparation and Extract Powder 베타글루칸Beta Glucan 함량 측정 Content measurement

상기 실시예 1 및 2 그리고 상기 비교예 1 및 2에서 제조한 배양액을 5일 간격으로 채취하여 100℃에서 3시간 추출하여 여과한 후 여액에 액량 대비 95% 알코올(v/v)을 3배량 첨가하여 다당체를 침전시켰다. 상기의 침전물을 원심분리하여 회수한 다음 50℃에서 진공건조시켜 상황버섯 균사체 추출분말을 제조하였다.The cultures prepared in Examples 1 and 2 and Comparative Examples 1 and 2 were collected at 5 day intervals, extracted at 100 ° C. for 3 hours, filtered, and then 3 times the amount of 95% alcohol (v / v) was added to the filtrate. To precipitate the polysaccharide. The precipitate was recovered by centrifugation and then dried under vacuum at 50 ° C. to prepare a situation mushroom mycelium extract powder.

베타-글루칸의 측정은 메가자임 β-글루칸 분석 키트(Megazyme β-glucan assay kit; Megazyme International Ireland Ltd., Ireland)를 이용하여 총 글루칸과 글루칸 이외의 당함량을 구한 후, 알파-글루칸과 글루칸 이외의 당함량의 값을 빼서 구하였다.Beta-glucan was measured by using a Megazyme β-glucan assay kit (Megazyme International Ireland Ltd., Ireland) to determine the sugar content other than total glucan and glucan, and then excluding alpha-glucan and glucan. Obtained by subtracting the value of sugar content.

각각의 0.5mm 크기 이하의 균사체 분말 100mg에 1.5mL 염산(37%, v/v)을 첨가 후, 내용물을 잘 섞어준 다음, 30℃에서 60분 동안 15분 간격으로 잘 섞어 주었다. 전분 및 단백질을 분해, 제거시키기 위하여 증류수 10mL씩을 첨가 후 2시간 동안 끓는 물(100℃)에 방치하였다.To 100 mg of mycelial powder of 0.5 mm or less, 1.5 mL of hydrochloric acid (37%, v / v) was added, and then the contents were mixed well, followed by mixing at 30 ° C. for 60 minutes at 15 minutes intervals. In order to decompose and remove starch and protein, 10 mL of distilled water was added thereto and then left in boiling water (100 ° C.) for 2 hours.

그 후, 실온에서 내용물을 식힌 후, 2N KOH를 첨가하여 pH를 맞추고, 200mM 소듐 아세테이트 완충액(sodium acetate buffer; pH 5.0)로 희석하였다. 희석된 내용물은 원심분리를 통해 상층액을 얻어 상층액 100uL에 엑솔, 3-β-글루카네이즈(exo1,3-β-Glucanase; 100U/mL) + β-글루코시다아제(β-Glucosidase; 20 unit/mL) 용액을 100uL씩 첨가하여 1시간 동안 40℃에서 방치하고, 글루코즈 측정 용액(glucose determination reagent) 3mL을 첨가한 후 40℃에서 20분 동안 방치하였다. 그 후, 510 nm에서 흡광도를 측정하여 총 글루칸과 글루칸 이외의 당 함량값을 얻었다. 또한 알파-글루칸과 글루칸 이외의 당함량값은 균사체분말 100mg에 2M KOH 2mL를 넣고 마그네틱바를 이용하여 얼음이 채워진 수욕에서 20분간 교반한 후에 1.2 M 소듐 아세테이트 완충액(Sodium acetate buffer; pH 3.8) 8mL를 첨가하였다.The contents were then cooled to room temperature, adjusted to pH by addition of 2N KOH, and diluted with 200 mM sodium acetate buffer (pH 5.0). Diluted contents were centrifuged to obtain supernatant, and then, 100 μL of the supernatant was extracted with axole, 3-β-glucanase (exo1,3-β-Glucanase; 100 U / mL) + β-glucosidase (β-Glucosidase; 20). unit / mL) solution was added to each 100uL and left for 1 hour at 40 ℃, 3mL of glucose determination reagent was added and then left at 40 ℃ 20 minutes. Thereafter, absorbance was measured at 510 nm to obtain a total glucan and sugar content values other than glucan. In addition, sugar content values other than alpha-glucan and glucan were added to 2 mg KOH 2mL in 100mg of mycelium powder, and stirred for 20 minutes in an ice-filled water bath using a magnetic bar, followed by 8mL of 1.2M sodium acetate buffer (pH 3.8). Added.

또한 아밀로글루코시다아제(Amyloglucosidase; 1630 unit/mL) + 인버타아제(Invertase; 500 unit/mL) 용액을 200uL 첨가한 후, 40℃에서 30분 동안 방치하고, 200nM 소듐 아세테이트 완충액(sodium acetate buffer; pH 5.0)을 이용하여 희석하였다. 그 다음 글루코즈 측정 용액(glucose determination reagent) 3mL를 첨 가한 후 20분 동안 40℃에서 방치하였다. 그 후 510nm에서 흡광도를 측정하여 알파-글루칸과 글루칸 이외의 당함량값을 얻었다.In addition, 200uL of a solution of Amyloglucosidase (Amyloglucosidase; 1630 unit / mL) + Invertase (500 unit / mL) was added thereto, and then allowed to stand at 40 ° C for 30 minutes, followed by 200 nM sodium acetate buffer. ; pH 5.0). Then, 3 mL of glucose determination reagent was added and left at 40 ° C. for 20 minutes. The absorbance was then measured at 510 nm to obtain sugar content values other than alpha-glucan and glucan.

베타글루칸 함량은 아래의 식을 통해 구했다.Beta-glucan content was calculated by the following equation.

베타글루칸 = (총 글루칸 + 글루칸 이외의 당) - (알파 글루칸 + 글루칸 이외의 당)Beta glucan = (total glucan + sugar other than glucan)-(alpha glucan + sugar other than glucan)

< 실험 결과 ><Experimental Results>

상기에서 제조된 균사체추출분말을 배양액 대비 수율을 측정하여 표 1에 나타내었다The mycelium extract powder prepared above was measured and compared with the culture solution, and the results are shown in Table 1.

< 표 1 > 상황버섯 균사체 추출분말 수율(%)<Table 1> Yield of powdered mushroom mycelium extract (%)

배양일수Incubation days 5일5 days 10일10 days 15일15th 20일20 days 실시예 1Example 1 0.270.27 0.580.58 0.690.69 0.660.66 실시예 2Example 2 0.290.29 0.410.41 0.610.61 0.620.62 비교예 1Comparative Example 1 0.170.17 0.250.25 0.310.31 0.390.39 비교예 2Comparative Example 2 0.120.12 0.210.21 0.340.34 0.350.35

상기 표 1에 나타나 있듯이, 배양일수가 15일째 한약재 추출물을 첨가한 포테이토 덱스트로우즈 배지에서 배양된 실시예 1에서 가장 높은 상황버섯 균사체 추출분말을 얻을 수 있음을 알게 되었다. 한약재 추출물이 첨가된 실시예 1과 2의 추출분말 수율이 한약재 추출물이 첨가되지않은 비교예 1과 2보다 월등히 높은 것을 알 수있었다.As shown in Table 1, it was found that the highest number of situation mushroom mycelium extract powder in Example 1 cultured in potato dextrose medium to which the cultivation days were added on the 15th day. It was found that the extraction powder yields of Examples 1 and 2 to which the medicinal herb extract was added were significantly higher than Comparative Examples 1 and 2 to which the medicinal herb extract was not added.

또한, 실시예 1 및 2, 그리고 비교예 2는 배양일수가 15일 이후에는 상황버섯 균사체 추출분말 수율이 늘어나지 않는 것을 알 수 있어 배양일을 15일로 하는 것이 경제적으로도 가장 적합하며 상황버섯 균사체 추출분말 수율도 가장 높음을 알 수 있었다.In addition, Examples 1 and 2, and Comparative Example 2 can be seen that the yield of the situation mushroom mycelium extract powder does not increase after 15 days of incubation, it is economically most suitable to use the culture date 15 days and extract the situation mushroom mycelium The powder yield was also found to be the highest.

< 표 2 > 상황버섯 균사체 추출분말 중 베타글루칸 함량(%)<Table 2> Beta-glucan content (%) in the situation mushroom mycelium extract powder

배양일수Incubation days 5일5 days 10일10 days 15일15th 20일20 days 실시예 1Example 1 31.831.8 37.537.5 49.749.7 51.151.1 실시예 2Example 2 30.430.4 33.633.6 38.438.4 39.739.7 비교예 1Comparative Example 1 25.925.9 26.426.4 29.229.2 33.733.7 비교예 2Comparative Example 2 23.423.4 27.627.6 28.728.7 31.431.4

상기 표 2에 나와 있듯이, 한약재 추출물을 첨가한 실시예 1 및 2의 베타글루칸 함량이 한약재 추출물을 첨가하지 않은 비교예 1 및 2보다 함량이 높은 것을 알 수 있었다. 또한 한약재 추출물을 첨가한 포테이토 덱스트로우즈 배지에서 배양된 실시예 1에서 가장 높은 베타글루칸 함량이 월등히 높은 것을 알 수 있다. 실시예 1과 2에서 배양 10일에서 15일 사이에 베타글루칸 함량이 각각 12.2%와 4.3%가 증가하여 가장 높게 증가하는 것을 알 수 있었으며 그 이후의 배양에서는 2% 미만으로 증가하는 것을 알 수 있었다.As shown in Table 2, the beta glucan content of Examples 1 and 2 to which the medicinal herb extract was added was higher than that of Comparative Examples 1 and 2 to which the medicinal herb extract was not added. In addition, it can be seen that the highest beta glucan content was significantly higher in Example 1 cultured in a potato dextrose medium to which the medicinal herb extract was added. In Examples 1 and 2, the beta glucan content increased 12.2% and 4.3%, respectively, between 10 and 15 days of cultivation, and the highest increase was found to be less than 2% in subsequent cultures. .

실시예 1과 2를 비교했을 때는 포테이토 덱스트로우즈에 한약재 추출물을 넣는 것이 10% 이상 베타글루칸 함량이 높은 것을 알 수 있었다. 한약재 추출물을 첨가한 실시예 1 및 2의 베타글루칸 함량이 한약재 추출물을 첨가하지 않은 비교예 1 및 2보다 높은 것을 알 수 있었다. Comparing Examples 1 and 2, it was found that adding the medicinal herb extract to potato dextrose was higher than 10% of the beta glucan. It was found that the beta glucan content of Examples 1 and 2 to which the medicinal herb extract was added was higher than Comparative Examples 1 and 2 to which the medicinal herb extract was not added.

상황버섯 자실체를 인공재배하는 종래의 방법은 3~6개월이라는 장기간의 배양기간이 소요되어 대량생산이 어렵고 수요를 충족시키지 못하고 있다. 반면 본 발명자들은 상황버섯 균사체를 한약재 추출물에 배양하여 배양 시간을 단축시킬 수 있을 뿐만 아니라 단시간에 다량의 베타글루칸을 얻을 수 있었다. 따라서 상황버섯 배양액 중 베타글루칸 함량을 높일 수 있는 상황버섯 균사체 배양 배지는 상황버섯 균사체 인공 배양에 널리 활용될 수 있다.  The conventional method of artificially cultivating the situation mushroom fruiting body takes a long culture period of 3 to 6 months, making mass production difficult and not meeting the demand. On the other hand, the present inventors can not only shorten the incubation time by culturing the situation mushroom mycelium in the herbal medicine extract, but also obtain a large amount of beta glucan in a short time. Therefore, the situation mushroom mycelium culture medium which can increase the content of beta glucan in the situation mushroom culture medium can be widely used for artificial culture of situation mushroom mycelium.

Claims (3)

인삼, 황기, 애엽(약쑥), 당귀, 상백피(뽕나무껍질) 및 오가피 추출물로 구성된 한약재 추출물 5-20 중량%, 감자전분 0.2-1 중량%, 덱스트로우즈 1-5 중량% 및 증류수 75-90 중량%를 포함하는 것을 특징으로 하는 상황버섯 균사체 배양용 배지 조성물.Herbal medicine extract consisting of ginseng, Astragalus, larvae, Mugwort, Angelica bark, Mulberry bark and Ogapi extract 5-20% by weight, potato starch 0.2-1% by weight, dextrose 1-5% by weight and distilled water 75-90 Situation mushroom mycelium culture medium composition comprising a weight%. 인삼, 황기, 애엽(약쑥), 당귀, 상백피(뽕나무껍질) 및 오가피 추출물로 구성된 한약재 추출물 5-20 중량%, 맥아추출물 1-5 중량% 및 증류수 75-90 중량%를 포함하는 것을 특징으로 하는 상황버섯 균사체 배양용 배지 조성물.Herbal medicine extract consisting of ginseng, Astragalus, larvae (mugwort), Angelica, Sangbaekpi (Mulberry bark) and Ogapi extract 5-20% by weight, malt extract 1-5% by weight and distilled water 75-90% by weight Situation mushroom mycelia culture medium composition. 제 1 항 또는 제 2 항에 있어서, 상기 한약재 추출물은 인삼 200g, 황기 200g, 애엽(약쑥) 200g, 당귀 200g, 상백피(뽕나무껍질) 100g 및 오가피 100g을 2L의 정제수에 첨가한 후 110℃에서 2시간 중탕하여 추출된 것을 특징으로 하는 상황버섯 균사체 배양용 배지 조성물.The method of claim 1 or 2, wherein the herbal extract is ginseng 200g, Astragalus 200g, 200g of Aegye (mugwort) 200g, Angelica 200g, 100g of Morus bark (Mulberry bark) and 100g of ogapi in 2L purified water and then 2 at 110 ℃ Situation mushroom mycelium culture medium composition, characterized in that extracted by hot water bath.
KR1020080079845A 2008-08-14 2008-08-14 Medium composition for Phellinus linteus culture KR101124783B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020080079845A KR101124783B1 (en) 2008-08-14 2008-08-14 Medium composition for Phellinus linteus culture

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020080079845A KR101124783B1 (en) 2008-08-14 2008-08-14 Medium composition for Phellinus linteus culture

Publications (2)

Publication Number Publication Date
KR20100021110A KR20100021110A (en) 2010-02-24
KR101124783B1 true KR101124783B1 (en) 2012-03-23

Family

ID=42090944

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020080079845A KR101124783B1 (en) 2008-08-14 2008-08-14 Medium composition for Phellinus linteus culture

Country Status (1)

Country Link
KR (1) KR101124783B1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101330487B1 (en) * 2011-04-27 2013-11-15 곽성인 CULTIVATING METHOD OF MUSHROOM INCLUDING Acanthopanax senticosus HOT WATER EXTRACT
KR20240043961A (en) 2022-09-28 2024-04-04 주식회사 동성푸드 Production Method of Livestock Products

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102948370A (en) * 2012-12-13 2013-03-06 向华 Rapid propagation method of nothapodytes pittosporoides
KR101638350B1 (en) * 2016-03-10 2016-07-11 농업회사법인 시드바이오텍 주식회사 Method of producing health functional food with peanut sprout
CN105875155A (en) * 2016-04-21 2016-08-24 厦门人天景农业科技有限公司 Organic planting method of angelica sinensis
CN112568081A (en) * 2020-12-08 2021-03-30 岷县中药材技术推广站 Angelica sinensis hill-drop seedling method
CN116420741B (en) * 2023-03-21 2024-01-23 吉林桑黄生物科技集团有限公司 Composite biological agent for mulberry Huang Chongzhi and planting method of high-yield phellinus linteus
CN116391568B (en) * 2023-05-19 2023-08-29 吉林农业科技学院 Phellinus linteus strain culture medium and preparation method thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100201051B1 (en) 1996-07-03 1999-06-15 Lee Jung Sik The method for culturing cordyceps
KR20010027806A (en) * 1999-09-15 2001-04-06 김천환 Culturing method of cordyceps spp
KR20050012053A (en) * 2003-07-24 2005-01-31 에이치엔엠바이오(주) Mushroom culture method
KR20050113949A (en) * 2004-05-31 2005-12-05 주식회사한국신약 The methods of liquid culture for the mass production of inonotus obliquus

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100201051B1 (en) 1996-07-03 1999-06-15 Lee Jung Sik The method for culturing cordyceps
KR20010027806A (en) * 1999-09-15 2001-04-06 김천환 Culturing method of cordyceps spp
KR20050012053A (en) * 2003-07-24 2005-01-31 에이치엔엠바이오(주) Mushroom culture method
KR20050113949A (en) * 2004-05-31 2005-12-05 주식회사한국신약 The methods of liquid culture for the mass production of inonotus obliquus

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101330487B1 (en) * 2011-04-27 2013-11-15 곽성인 CULTIVATING METHOD OF MUSHROOM INCLUDING Acanthopanax senticosus HOT WATER EXTRACT
KR20240043961A (en) 2022-09-28 2024-04-04 주식회사 동성푸드 Production Method of Livestock Products

Also Published As

Publication number Publication date
KR20100021110A (en) 2010-02-24

Similar Documents

Publication Publication Date Title
KR101124783B1 (en) Medium composition for Phellinus linteus culture
CN103156052B (en) Submerged fermentation technology of producing immunological enhancement active materials of inonotus obliquus
KR101652035B1 (en) Method for production of fungi mycelia complex with Inonotus obliquus, Phellinus linteus and parassis Crispa
KR101082246B1 (en) Nuruk containing salicornia herbacea and preparation method of the same
CN114592013A (en) Preparation method and application of cordyceps sobolifera enzyme
KR20170022798A (en) Methods for manufacturing the mixing extracts of Inonotus obliquus, Phellinus linteus and Sparassis crispa and its mixing extracts
KR101196736B1 (en) Methods of producing of Phellinus linteus mycellium having high ß-glucan content
CN106431572A (en) Lucid-ganoderma cultivation method for increasing ganoderan and selenium content
KR100844980B1 (en) Method of producing a Healthy Mulberry Leaf Food by culture of Mushroom Mycelia
KR20070121073A (en) The cultivation method of phellinus linteus mycellia having high beta-glucan content
KR100706132B1 (en) Composition for the culturing of Phellinus linteus mycelium
KR102050318B1 (en) Fermented Rice Bran Extract and Preparing Method Thereof
KR102117227B1 (en) a phellinus linteus cultivating method using Cudrania tricuspidata and the phellinus linteus
KR100393254B1 (en) A culture medium for Phellinus linteus and a culture method using thereof
KR20200108748A (en) The cultivation method of sang hwang mushroom mycelium with high content of beta-glucan
WO2019209706A2 (en) Bioactive fungal compounds produced by solid-state fermentation
KR20120132646A (en) Liquid cultivating method of Phellinus linteus increasing antioxidant and immunostimulating activity
KR20140024549A (en) Method for manufacturing functional mushroom rice
KR100218897B1 (en) Medium for phellinus linteus culture and culturing method of phellinus linteus with the medium
KR102357617B1 (en) Composition comprising extracts of mushroom mixed mycelia, Aconogonon alpinum, Orostachys japonicus and Amaranthus mangostanus for prevention or treating gout
KR101419217B1 (en) Method for bioconversion of quercetin 3,4&#39;-O-β-D-glucoside in onion to isoquercitrin using Aureobasidium pullulans
KR100900686B1 (en) Composition and manufacturing method of phellinus linteus mycelium liquid culture medium and manufacturing method of phellinus linteus mycelium and domestic animal feed with phellinus linteus mycelium
KR100852490B1 (en) Inonotus linteus producing ?-amylase and method of producing Inonotus linteus mycelia having enhanced polysaccharide content using the same
KR101679114B1 (en) Method of preparing nuruk and fermented aLcohoL using the same by inocuLating 3 strains Aspergillus oryzae into yam and Chrysanthemum indicum
KR20030029423A (en) Coriolus versicolor Mycellium beverage and Process for Preparing mycellium beverage

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee